Gave an interview on the biotech sector, said we are in the middle innings of a bull super cycle. While talking about Amgen and Gilead, the interviewer mentioned that King had recommended to him last year to buy 10,000 shares of Keryx and regretted not taking his advice. King said yes, and that he projected Keryx to be strongly profitable in 2015. Nothing new, but it did feel good to hear.
Heard it live and again yesterday on Bloomberg rewind. KERX is very well known as a safe bet moving forward. This is a 20+ stock when it is all said and done. Very happy that the dialysis sector is about to get blindsided by a 9% reduction in medicare funding. The 700 million per year savings companies like Devita would get by implementing Zerenex would compensate for that massive (around 350 million a year) lost in revenue. They will be salivating for this drug until approval next year.
cossack...thanks for the post....
I caught the tail end of the broadcast and missed the part about KERX ....My son mentioned it to me
when he came home from work ...Also glad we all took the"advice" even though we didn't have the benefit of King's counsel.